Hernandez-Gea V - Search Results

1

DNA methylation-based prognosis and epidrivers in hepatocellular carcinoma.

Villanueva A, Portela A, Sayols S, Battiston C, Hoshida Y, Méndez-González J, Imbeaud S, Letouzé E, Hernandez-Gea V, Cornella H, Pinyol R, Solé M, Fuster J, Zucman-Rossi J, Mazzaferro V, Esteller M, Llovet JM; HEPTROMIC Consortium. Villanueva A, et al. Hepatology. 2015 Jun;61(6):1945-56. doi: 10.1002/hep.27732. Epub 2015 Mar 18. Hepatology. 2015. PMID: 25645722 Free article.

2

Reduced hepatic stellate cell expression of Kruppel-like factor 6 tumor suppressor isoforms amplifies fibrosis during acute and chronic rodent liver injury.

Ghiassi-Nejad Z, Hernandez-Gea V, Woodrell C, Lang UE, Dumic K, Kwong A, Friedman SL. Ghiassi-Nejad Z, et al. Hepatology. 2013 Feb;57(2):786-96. doi: 10.1002/hep.26056. Epub 2012 Dec 6. Hepatology. 2013. PMID: 22961688 Free PMC article.

3

Medical therapies for hepatocellular carcinoma: a critical view of the evidence.

Villanueva A, Hernandez-Gea V, Llovet JM. Villanueva A, et al. Nat Rev Gastroenterol Hepatol. 2013 Jan;10(1):34-42. doi: 10.1038/nrgastro.2012.199. Epub 2012 Nov 13. Nat Rev Gastroenterol Hepatol. 2013. PMID: 23147664 Review.

4

Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma.

Hernandez-Gea V, Toffanin S, Friedman SL, Llovet JM. Hernandez-Gea V, et al. Gastroenterology. 2013 Mar;144(3):512-27. doi: 10.1053/j.gastro.2013.01.002. Epub 2013 Jan 9. Gastroenterology. 2013. PMID: 23313965 Free PMC article. Review.

5

Management of small hepatocellular carcinoma in cirrhosis: focus on portal hypertension.

Hernandez-Gea V, Turon F, Berzigotti A, Villanueva A. Hernandez-Gea V, et al. World J Gastroenterol. 2013 Feb 28;19(8):1193-9. doi: 10.3748/wjg.v19.i8.1193. World J Gastroenterol. 2013. PMID: 23482437 Free PMC article. Review.

6

Oncolytic immunotherapeutic virus in HCC: can it compete with molecular therapies?

Hernandez-Gea V, Alsinet C, Llovet JM. Hernandez-Gea V, et al. J Hepatol. 2013 Oct;59(4):882-4. doi: 10.1016/j.jhep.2013.05.006. Epub 2013 May 11. J Hepatol. 2013. PMID: 23673136 Free article. No abstract available.

7

Idiopathic portal hypertension: natural history and long-term outcome.

Siramolpiwat S, Seijo S, Miquel R, Berzigotti A, Garcia-Criado A, Darnell A, Turon F, Hernandez-Gea V, Bosch J, Garcia-Pagán JC. Siramolpiwat S, et al. Hepatology. 2014 Jun;59(6):2276-85. doi: 10.1002/hep.26904. Epub 2014 Feb 28. Hepatology. 2014. PMID: 24155091

8

Obeticholic acid: a new light in the shadows treating portal hypertension?

Gracia-Sancho J, Hernández-Gea V, Garcia-Pagán JC. Gracia-Sancho J, et al. Hepatology. 2014 Jun;59(6):2072-3. doi: 10.1002/hep.27027. Epub 2014 Apr 28. Hepatology. 2014. PMID: 24452422 No abstract available.

9

Hepatocellular carcinoma: reasons for phase III failure and novel perspectives on trial design.

Llovet JM, Hernandez-Gea V. Llovet JM, et al. Clin Cancer Res. 2014 Apr 15;20(8):2072-9. doi: 10.1158/1078-0432.CCR-13-0547. Epub 2014 Mar 3. Clin Cancer Res. 2014. PMID: 24589894 Review.

10

The prognostic value of hepatic venous pressure gradient in patients with cirrhosis is highly dependent on the accuracy of the technique.

Silva-Junior G, Baiges A, Turon F, Torres F, Hernández-Gea V, Bosch J, García-Pagán JC. Silva-Junior G, et al. Hepatology. 2015 Nov;62(5):1584-92. doi: 10.1002/hep.28031. Epub 2015 Sep 30. Hepatology. 2015. PMID: 26238376

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

186 results

Search Page

Filters